TP53 and esophageal squamous cell carcinoma: The TP53 Arg/Arg genotype was significantly increased in ESCC cases compared with the control subjects (85.7 vs. 49.6%, P<0.001), resulting in an elevated ESCC risk (OR = 6.48, 95% CI = 4.65-9.03).